Literature DB >> 21128780

Use of a linear array for the detection of human papillomavirus genotypes in head and neck cancer.

Candice C Black1, Heather A Bentley, Thomas H Davis, Gregory J Tsongalis.   

Abstract

CONTEXT: Tumors of the head and neck commonly arise from the squamous and respiratory mucosa that lines the nasal and oral cavity, sinuses, pharynx, and larynx. The rate of oropharyngeal cancers diagnosed among Americans younger than 50 years is increasing. Infection of the oropharynx and tonsils by the human papillomavirus (HPV) has been linked to preneoplasia and cancer.
OBJECTIVES: To evaluate the Roche Linear Array HPV Genotyping test kit to identify, and then specifically genotype, HPV in formalin-fixed, paraffin-embedded tissues.
DESIGN: We evaluated the performance of this assay for accuracy, for intra-assay and interassay precision, and for its limit of detection, using materials with known HPV status. Sixteen tumor tissues with the following origins were evaluated: 1 ocular, 1 hypopharynx, 8 tonsil, 1 retromolar trigone, 3 tongue, 1 anal, and 1 lymph node. DNA from formalin-fixed, paraffin-embedded tumor sections was isolated and amplified in duplicate, with positive and negative controls, using primers specific to the polymorphic L1 region of the HPV genome. Thirty-seven genotypes were tested using the linear array. The amplified product (450 base pairs) was visualized by gel electrophoresis and, if positive, reflexed to HPV genotyping.
RESULTS: Nine of the 16 tumors analyzed were HPV positive. The detected genotypes included HPV 6, 16, and 69.
CONCLUSIONS: The Roche Linear Array HPV Genotyping test is an easy-to-use method for determining HPV genotype in the routine analysis of formalin-fixed, paraffin-embedded tumors. This assay is robust and can be performed routinely in a clinical laboratory setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21128780     DOI: 10.5858/2009-0592-OAR.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.

Authors:  Doreen Ramogola-Masire; Cindy M McGrath; Kurt T Barnhart; Harvey M Friedman; Nicola M Zetola
Journal:  Int J Gynecol Pathol       Date:  2011-11       Impact factor: 2.762

2.  Next-Generation Sequencing-Based HPV Genotyping Assay Validated in Formalin-Fixed, Paraffin-Embedded Oropharyngeal and Cervical Cancer Specimens.

Authors:  Nicholas P Ambulos; Lisa M Schumaker; Trevor J Mathias; Ruth White; Jennifer Troyer; David Wells; Kevin J Cullen
Journal:  J Biomol Tech       Date:  2016-03-07

3.  Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array.

Authors:  Jose M Godínez; Sara Tous; Nuria Baixeras; Judith Moreno-Crespi; María Alejo; Marylène Lejeune; Ignacio G Bravo; F Xavier Bosch; Silvia de Sanjosé
Journal:  Infect Agent Cancer       Date:  2011-11-18       Impact factor: 2.965

4.  Oncogenic HPV Types Infection in Adolescents and University Women from North Portugal: From Self-Sampling to Cancer Prevention.

Authors:  Jani Silva; Joana Ribeiro; Hugo Sousa; Fátima Cerqueira; Ana Luisa Teixeira; Ines Baldaque; Teresa Osório; Rui Medeiros
Journal:  J Oncol       Date:  2011-11-28       Impact factor: 4.375

5.  Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens.

Authors:  Isabella W Martin; Heather B Steinmetz; Claudine L Lefferts; Larry J Dumont; Laura J Tafe; Gregory J Tsongalis
Journal:  Pathogens       Date:  2012-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.